John Hynes - Publications

Affiliations: 
University of Pennsylvania, Philadelphia, PA, United States 

36/76 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 McDaniel J, Farley CA, Ramirez A, Sandhu B, Sarjeant A, Shi Q, Han A, Gallagher WP, Hynes J, Dhar TGM, Gonzalez-Bobes F, Coombs JR, Marcoux D. Discovery of Annulating Reagents Enabling the One-Step and Highly Stereoselective Synthesis of Cyclopentyl and Cyclohexyl Cores. Organic Letters. PMID 33351641 DOI: 10.1021/acs.orglett.0c03695  0.331
2020 Shi Q, Xiao Z, Yang MG, Marcoux D, Cherney RJ, Yip S, Li P, Wu DR, Weigelt CA, Sack J, Khan J, Ruzanov M, Wang J, Yarde M, Ellen Cvijic M, ... ... Hynes J, et al. Tricyclic Sulfones as Potent, Selective and Efficacious RORγt Inverse Agonists - Exploring C6 and C8 SAR Using Late-Stage Functionalization. Bioorganic & Medicinal Chemistry Letters. 127521. PMID 32882417 DOI: 10.1016/J.Bmcl.2020.127521  0.342
2020 Marcoux D, Beaudoin Bertrand M, Weigelt CA, Yip S, Galella M, Park H, Wu DR, Wang J, Yarde M, Ellen Cvijic M, Li S, Hynes J, Tino JA, Zhao Q, Murali Dhar TG. Annulation Reaction Enables the identification of an Exocyclic Amide Tricyclic Chemotype as Retinoic Acid Receptor-Related Orphan Receptor Gamma (RORγ/RORc) Inverse Agonists. Bioorganic & Medicinal Chemistry Letters. 127466. PMID 32763309 DOI: 10.1016/J.Bmcl.2020.127466  0.383
2020 Nair S, Kumar SR, Paidi VR, Sistla R, Kantheti D, Polimera SR, Thangavel S, Mukherjee AJ, Das M, Bhide RS, Pitts WJ, Murugesan N, Dudhgoankar S, Nagar J, Subramani S, ... ... Hynes J, et al. Optimization of Nicotinamides as Potent and Selective IRAK4 Inhibitors with Efficacy in a Murine Model of Psoriasis. Acs Medicinal Chemistry Letters. 11: 1402-1409. PMID 32676146 DOI: 10.1021/Acsmedchemlett.0C00082  0.306
2019 Shi Q, Greenwood NS, Meehan MC, Park H, Galella M, Sandhu B, Khandelwal P, Coombs JR, Gallagher WP, Guerrero CA, Hynes J, Dhar TGM, Gonzalez Bobes F, Marcoux D. One-Step Diastereoselective Pyrrolidine Synthesis Using a Sulfinamide Annulating Reagent. Organic Letters. PMID 31647672 DOI: 10.1021/Acs.Orglett.9B03560  0.404
2019 Marcoux D, Duan JJ, Shi Q, Cherney RJ, Srivastava AS, Cornelius L, Batt DG, Liu Q, Beaudoin Bertrand M, Weigelt CA, Khandelwal P, Pushparaj S, Selvakumar K, Karmakar A, Gupta AK, ... ... Hynes J, et al. Rationally Designed, Conformationally Constrained Inverse Agonists of RORγt ‒ Identification of a Potent, Selective Series with Biologic-Like In Vivo Efficacy. Journal of Medicinal Chemistry. PMID 31638797 DOI: 10.1021/Acs.Jmedchem.9B01369  0.308
2019 Arunachalam PN, Kuppusamy P, Ganesan S, Krishnamoorthy S, Nimje RY, Jarugu LB, Chikkananjaiah NK, Reddy CA, Anjanappa P, Botlagunta M, Vanteru S, Maddala N, Shankar M, Nair S, Hynes J, et al. Development of a Scalable Synthesis for the Potent Kinase Inhibitor BMS-986236; 1-(5-(4-(3-Hydroxy-3-methylbutyl)-1H-1,2,3-triazol-1-yl)-4-(isopropylamino)pyridin-2-yl)-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile Organic Process Research & Development. 23: 912-918. DOI: 10.1021/Acs.Oprd.9B00023  0.305
2017 Shi Q, Meehan MC, Galella M, Park H, Khandelwal P, Hynes J, Dhar TGM, Marcoux D. Protected Chloroethyl and Chloropropyl Amines as Conformationally Unrestricted Annulating Reagents. Organic Letters. PMID 29283585 DOI: 10.1021/Acs.Orglett.7B03548  0.343
2017 Kempson J, Ovalle D, Guo J, Wrobleski ST, Lin S, Spergel SH, Duan JJ, Jiang B, Lu Z, Das J, Yang BV, Hynes J, Wu H, Tokarski J, Sack JS, et al. Discovery of highly potent, selective, covalent inhibitors of JAK3. Bioorganic & Medicinal Chemistry Letters. PMID 28927786 DOI: 10.1016/J.Bmcl.2017.09.023  0.337
2017 Liu Q, Shi Q, Marcoux D, Batt DG, Cornelius L, Qin LY, Ruan Z, Neels J, Beaudoin Bertrand M, Srivastava AS, Li L, Cherney RJ, Gong H, Watterson SH, Weigelt C, ... ... Hynes J, et al. Identification of a potent, selective, and efficacious phosphatidylinositol 3-kinase δ (PI3Kδ) inhibitor for the treatment of immunological disorders. Journal of Medicinal Chemistry. PMID 28541707 DOI: 10.1021/Acs.Jmedchem.7B00618  0.322
2017 Hynes J, Wu H, Kempson J, Duan JJ, Lu Z, Jiang B, Stachura S, Tokarski JS, Sack JS, Khan JA, Lippy JS, Zhang RF, Pitt S, Shen G, Gillooly K, et al. Discovery of potent and efficacious pyrrolopyridazines as dual JAK1/3 inhibitors. Bioorganic & Medicinal Chemistry Letters. PMID 28539220 DOI: 10.1016/J.Bmcl.2017.05.043  0.351
2017 Marcoux D, Qin LY, Ruan Z, Shi Q, Ruan Q, Weigelt C, Qiu H, Schieven G, Hynes J, Bhide R, Poss M, Tino J. Identification of highly potent and selective PI3Kδ inhibitors. Bioorganic & Medicinal Chemistry Letters. PMID 28209465 DOI: 10.1016/J.Bmcl.2017.01.077  0.322
2015 Hong Y, Hynes J, Tian Y, Balasubramanian B, Bonacorsi S. Synthesis and characterization of tritium labeled N-((R)-1-((S)-4-(4-chlorophenyl)-4-hydroxy-3,3-dimethylpiperidin-1-yl)-3-methyl-1-oxobutan-2-yl)-3-sulfamoylbenzamide. Journal of Labelled Compounds & Radiopharmaceuticals. 58: 414-8. PMID 26228905 DOI: 10.1002/Jlcr.3320  0.324
2015 Khan JA, Camac DM, Low S, Tebben AJ, Wensel DL, Wright MC, Su J, Jenny V, Gupta RD, Ruzanov M, Russo KA, Bell A, An Y, Bryson JW, Gao M, ... ... Hynes J, et al. Developing Adnectins that target SRC co-activator binding to PXR: a structural approach toward understanding promiscuity of PXR. Journal of Molecular Biology. 427: 924-42. PMID 25579995 DOI: 10.1016/J.Jmb.2014.12.022  0.355
2014 Duan JJ, Lu Z, Jiang B, Yang BV, Doweyko LM, Nirschl DS, Haque LE, Lin S, Brown G, Hynes J, Tokarski JS, Sack JS, Khan J, Lippy JS, Zhang RF, et al. Discovery of pyrrolo[1,2-b]pyridazine-3-carboxamides as Janus kinase (JAK) inhibitors. Bioorganic & Medicinal Chemistry Letters. 24: 5721-6. PMID 25453808 DOI: 10.1016/J.Bmcl.2014.10.061  0.364
2013 Gardner DS, Santella JB, Duncia JV, Carter PH, Dhar TG, Wu H, Guo W, Cavallaro C, Van Kirk K, Yarde M, Briceno SW, Grafstrom RR, Liu R, Patel SR, Tebben AJ, ... ... Hynes J, et al. The discovery of BMS-457, a potent and selective CCR1 antagonist. Bioorganic & Medicinal Chemistry Letters. 23: 3833-40. PMID 23707259 DOI: 10.1016/J.Bmcl.2013.04.079  0.379
2012 Cavallaro CL, Briceno S, Chen J, Cvijic ME, Davies P, Hynes J, Liu RQ, Mandlekar S, Rose AV, Tebben AJ, Van Kirk K, Watson A, Wu H, Yang G, Carter PH. Discovery and lead optimization of a novel series of CC chemokine receptor 1 (CCR1)-selective piperidine antagonists via parallel synthesis. Journal of Medicinal Chemistry. 55: 9643-53. PMID 23075267 DOI: 10.1021/Jm300896D  0.437
2012 Shi Z, Kiau S, Lobben P, Hynes J, Wu H, Parlanti L, Discordia R, Doubleday WW, Leftheris K, Dyckman AJ, Wrobleski ST, Dambalas K, Tummala S, Leung S, Lo E. Development of a practical synthesis of a p38 kinase inhibitor via a safe and robust amination Organic Process Research and Development. 16: 1618-1625. DOI: 10.1021/Op300181R  0.367
2010 Carter PH, Hynes J. N-aryl pyrazoles, indazoles and azaindazoles as antagonists of CC chemokine receptor 1: Patent cooperation treaty applications WO2010/036632, WO2009/134666 and WO2009/137338 Expert Opinion On Therapeutic Patents. 20: 1609-1618. PMID 20858032 DOI: 10.1517/13543776.2010.518144  0.318
2010 Liu C, Lin J, Wrobleski ST, Lin S, Hynes J, Wu H, Dyckman AJ, Li T, Wityak J, Gillooly KM, Pitt S, Shen DR, Zhang RF, McIntyre KW, Salter-Cid L, et al. Discovery of 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases. Journal of Medicinal Chemistry. 53: 6629-39. PMID 20804198 DOI: 10.1021/Jm100540X  0.333
2010 Lin S, Wrobleski ST, Hynes J, Pitt S, Zhang R, Fan Y, Doweyko AM, Kish KF, Sack JS, Malley MF, Kiefer SE, Newitt JA, McKinnon M, Trzaskos J, Barrish JC, et al. Utilization of a nitrogen-sulfur nonbonding interaction in the design of new 2-aminothiazol-5-yl-pyrimidines as p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20: 5864-8. PMID 20732813 DOI: 10.1016/J.Bmcl.2010.07.102  0.353
2009 Zhao R, Wang B, Wu H, Hynes J, Leftheris K, Balasubramanian B, Barrish JC, Chen B. Improved procedure for the preparation of 7-methoxy-2-methyl-1-(2-morpholinoethyl)-1H-indole-3-carboxylic acid, key intermediate in the synthesis of novel 3-amidoindole and indolopyridone cannabinoid ligands Arkivoc. 2010. DOI: 10.3998/Ark.5550190.0011.610  0.348
2008 Wrobleski ST, Lin S, Hynes J, Wu H, Pitt S, Shen DR, Zhang R, Gillooly KM, Shuster DJ, McIntyre KW, Doweyko AM, Kish KF, Tredup JA, Duke GJ, Sack JS, et al. Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38 alpha MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18: 2739-44. PMID 18364256 DOI: 10.1016/J.Bmcl.2008.02.067  0.375
2008 Hynes J, Wu H, Pitt S, Shen DR, Zhang R, Schieven GL, Gillooly KM, Shuster DJ, Taylor TL, Yang X, McIntyre KW, McKinnon M, Zhang H, Marathe PH, Doweyko AM, et al. The discovery of (R)-2-(sec-butylamino)-N-(2-methyl-5-(methylcarbamoyl)phenyl) thiazole-5-carboxamide (BMS-640994)-A potent and efficacious p38alpha MAP kinase inhibitor. Bioorganic & Medicinal Chemistry Letters. 18: 1762-7. PMID 18313298 DOI: 10.1016/J.Bmcl.2008.02.031  0.349
2008 Hynes J, Dyckman AJ, Lin S, Wrobleski ST, Wu H, Gillooly KM, Kanner SB, Lonial H, Loo D, McIntyre KW, Pitt S, Shen DR, Shuster DJ, Yang X, Zhang R, et al. Design, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38alpha mitogen-activated protein kinase inhibitors. Journal of Medicinal Chemistry. 51: 4-16. PMID 18072718 DOI: 10.1021/Jm7009414  0.352
2007 Parlanti L, Discordia RP, Hynes J, Miller MM, O'Grady HR, Shi Z. Amination of heterocyclic compounds with o-benzoylhydroxylamine derivatives. Organic Letters. 9: 3821-4. PMID 17718497 DOI: 10.1021/Ol701730R  0.374
2005 Hynes J, Leftheri K. Small molecule p38 inhibitors: novel structural features and advances from 2002-2005. Current Topics in Medicinal Chemistry. 5: 967-85. PMID 16178741 DOI: 10.2174/1568026054985920  0.338
2004 Leftheris K, Ahmed G, Chan R, Dyckman AJ, Hussain Z, Ho K, Hynes J, Letourneau J, Li W, Lin S, Metzger A, Moriarty KJ, Riviello C, Shimshock Y, Wen J, et al. The discovery of orally active triaminotriazine aniline amides as inhibitors of p38 MAP kinase. Journal of Medicinal Chemistry. 47: 6283-91. PMID 15566298 DOI: 10.1021/Jm049521D  0.39
2004 Hynes J, Doubleday WW, Dyckman AJ, Godfrey JD, Grosso JA, Kiau S, Leftheris K. N-Amination of pyrrole and indole heterocycles with monochloramine (NH2Cl). The Journal of Organic Chemistry. 69: 1368-71. PMID 14961694 DOI: 10.1021/Jo035587P  0.384
2004 Abrous L, Jokiel PA, Friedrich SR, Hynes J, Smith AB, Hirschmann R. Novel chimeric scaffolds to extend the exploration of receptor space: hybrid beta-D-glucose-benzoheterodiazepine structures for broad screening. Effect of amide alkylation on the course of cyclization reactions. The Journal of Organic Chemistry. 69: 280-302. PMID 14725439 DOI: 10.1021/Jo0352068  0.612
2003 Wrobleski ST, Chen P, Hynes J, Lin S, Norris DJ, Pandit CR, Spergel S, Wu H, Tokarski JS, Chen X, Gillooly KM, Kiener PA, McIntyre KW, Patil-Koota V, Shuster DJ, et al. Rational design and synthesis of an orally active indolopyridone as a novel conformationally constrained cannabinoid ligand possessing antiinflammatory properties. Journal of Medicinal Chemistry. 46: 2110-6. PMID 12747783 DOI: 10.1021/Jm020329Q  0.381
2002 Hynes J, Leftheris K, Wu H, Pandit C, Chen P, Norris DJ, Chen BC, Zhao R, Kiener PA, Chen X, Turk LA, Patil-Koota V, Gillooly KM, Shuster DJ, McIntyre KW. C-3 Amido-indole cannabinoid receptor modulators. Bioorganic & Medicinal Chemistry Letters. 12: 2399-402. PMID 12161142 DOI: 10.1016/S0960-894X(02)00466-3  0.33
2002 Hynes J, Nasser T, Overman LE, Watson DA. Preparation of alpha-sulfenyl enones by thermal fragmentation of beta-sulfenyl enol triflates. Organic Letters. 4: 929-31. PMID 11893188 DOI: 10.1021/Ol017303Y  0.614
2001 Abrous L, Hynes J, Friedrich SR, Smith AB, Hirschmann R. Design and synthesis of novel scaffolds for drug discovery: hybrids of beta-D-glucose with 1,2,3,4-tetrahydrobenzo[e][1,4]diazepin-5-one, the corresponding 1-oxazepine, and 2- and 4-pyridyldiazepines. Organic Letters. 3: 1089-92. PMID 11277802 DOI: 10.1021/Ol015698F  0.607
1996 Hirschmann R, Yao W, Cascieri MA, Strader CD, Maechler L, Cichy-Knight MA, Hynes J, van Rijn RD, Sprengeler PA, Smith AB. Synthesis of potent cyclic hexapeptide NK-1 antagonists. Use of a minilibrary in transforming a peptidal somatostatin receptor ligand into an NK-1 receptor ligand via a polyvalent peptidomimetic. Journal of Medicinal Chemistry. 39: 2441-8. PMID 8691440 DOI: 10.1021/Jm960281E  0.594
1995 Hirschmann R, Hynes J, Spoors P, Smith AB. Chemoselective monoalkylation of 5-trifluoroacetamido- and 5-acetamido-1-pentanol derivatives via N,O-bisdeprotonation. Quantitation of evolved H2 as a probe of anion formation Tetrahedron Letters. 36: 2373-2376. DOI: 10.1016/0040-4039(95)00280-P  0.543
Low-probability matches (unlikely to be authored by this person)
2018 Ruepp S, Janovitz E, Brodie T, White R, Santella J, Hynes J, Carman J, Pan D, Wu Y, Hanumegowda U, Gemzik B, Megill J, DiPiero J, Drexler D, Su CC, et al. Assessing the risk of drug crystallization in vivo. Journal of Pharmacological and Toxicological Methods. PMID 30553974 DOI: 10.1016/J.Vascn.2018.12.003  0.3
2020 Xiao HY, Li N, Duan JJ, Jiang B, Lu Z, Ngu K, Tino J, Kopcho LM, Lu H, Chen J, Tebben AJ, Sheriff S, Chang CY, Yanchunas J, Calambur D, ... ... Hynes J, et al. Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design Approaches. Journal of Medicinal Chemistry. PMID 33261314 DOI: 10.1021/acs.jmedchem.0c01732  0.299
2014 Santella JB, Gardner DS, Duncia JV, Wu H, Dhar M, Cavallaro C, Tebben AJ, Carter PH, Barrish JC, Yarde M, Briceno SW, Cvijic ME, Grafstrom RR, Liu R, Patel SR, ... ... Hynes J, et al. Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritis. Journal of Medicinal Chemistry. 57: 7550-64. PMID 25101488 DOI: 10.1021/Jm5003167  0.295
2015 Liu C, Lin J, Hynes J, Wu H, Wrobleski ST, Lin S, Dhar TG, Vrudhula VM, Sun JH, Chao S, Zhao R, Wang B, Chen BC, Everlof G, Gesenberg C, et al. Discovery of ((4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-f][1,2,4]triazine-6-carbonyl)(propyl)carbamoyloxy)methyl-2-(4-(phosphonooxy)phenyl)acetate (BMS-751324), a Clinical Prodrug of p38α MAP Kinase Inhibitor. Journal of Medicinal Chemistry. PMID 26359680 DOI: 10.1021/Acs.Jmedchem.5B00839  0.293
2014 Hynes J, Nair SK. Advances in the discovery of small-molecule IRAK4 inhibitors Annual Reports in Medicinal Chemistry. 49: 117-133. DOI: 10.1016/B978-0-12-800167-7.00009-2  0.274
2016 Dudhgaonkar S, Ranade S, Nagar J, Subramani S, Prasad DS, Karunanithi P, Srivastava R, Venkatesh K, Selvam S, Krishnamurthy P, Mariappan TT, Saxena A, Fan L, Stetsko DK, Holloway DA, ... ... Hynes J, et al. Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing Activity. Journal of Immunology (Baltimore, Md. : 1950). PMID 28003376 DOI: 10.4049/Jimmunol.1600583  0.271
2010 D'Arienzo CJ, Ji QC, Discenza L, Cornelius G, Hynes J, Cornelius L, Santella JB, Olah T. DBS sampling can be used to stabilize prodrugs in drug discovery rodent studies without the addition of esterase inhibitors. Bioanalysis. 2: 1415-22. PMID 21083342 DOI: 10.4155/Bio.10.94  0.26
2010 Wu H, Hynes J. Copper-catalyzed chlorination of functionalized arylboronic acids. Organic Letters. 12: 1192-5. PMID 20184339 DOI: 10.1021/Ol9029337  0.249
1995 Davidson P, Clerc M, Ghosh SS, Maliszewskyj NC, Heiney PA, Hynes J, Smith AB. Diffuse X-ray Scattering from Freely Suspended Strands of a Discotic Liquid Crystal Journal De Physique Ii. 5: 249-262. DOI: 10.1051/Jp2:1995127  0.163
2003 Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. The American Journal of Cardiology. 91: 15D-26D. PMID 12670638  0.077
2019 Hynes JP, Murray AS, Murray OM, Eustace SK, Gilchrist S, Dolan A, Lawler LP. Use of Lean Six Sigma methodology shows reduction of inpatient waiting time for peripherally inserted central catheter placement. Clinical Radiology. PMID 31128853 DOI: 10.1016/j.crad.2019.04.022  0.075
2019 Hynes JP, Hughes N, Cunningham P, Kavanagh EC, Eustace SJ. Whole-body MRI of bone marrow: A review. Journal of Magnetic Resonance Imaging : Jmri. PMID 31016800 DOI: 10.1002/jmri.26759  0.073
2003 Naccarelli GV, Wolbrette DL, Bhatta L, Khan M, Hynes J, Samii S, Luck J. A review of clinical trials assessing the efficacy and safety of newer antiarrhythmic drugs in atrial fibrillation. Journal of Interventional Cardiac Electrophysiology : An International Journal of Arrhythmias and Pacing. 9: 215-22. PMID 14574034  0.069
2002 Naccarelli GV, Hynes J, Wolbrette DL, Bhatta L, Khan M, Luck J. Maintaining stability of sinus rhythm in atrial fibrillation: antiarrhythmic drugs versus ablation. Current Cardiology Reports. 4: 418-25. PMID 12169239  0.062
2022 Hynes JP, Kavanagh EC. Complications in image-guided musculoskeletal injections. Skeletal Radiology. PMID 35622087 DOI: 10.1007/s00256-022-04076-8  0.045
2022 Murray OM, Hynes JP, Murray MA, Kavanagh EC. Voriconazole-induced periostitis post lung transplantation. Radiology Case Reports. 17: 1587-1590. PMID 35309380 DOI: 10.1016/j.radcr.2022.01.078  0.04
2008 Hynes JG. Discussion on treatment of captive elephants continues Journal of the American Veterinary Medical Association. 233: 1396. PMID 18985982  0.04
2018 Hynes JP, Walsh J, Farrell TP, Murray AS, Eustace SJ. Role of Musculoskeletal Radiology in Modern Sports Medicine. Seminars in Musculoskeletal Radiology. 22: 582-591. PMID 30399621 DOI: 10.1055/s-0038-1672191  0.037
2022 Glynn D, Hynes J, Richards K, O'Toole G, O'Keane C, Kavanagh E. Glomangiomatosis of the lower leg. Radiology Case Reports. 17: 963-966. PMID 35106104 DOI: 10.1016/j.radcr.2022.01.008  0.036
2018 Farrell TP, Adams NC, Walsh JP, Hynes J, Eustace SK, Kavanagh E. Musculoskeletal Imaging: Current Practice and Future Directions. Seminars in Musculoskeletal Radiology. 22: 564-581. PMID 30399620 DOI: 10.1055/s-0038-1673623  0.035
2021 Zoga AC, Kamel SI, Hynes JP, Kavanagh EC, O'Connor PJ, Forster BB. The Evolving Roles of MRI and Ultrasound in First-Line Imaging of Rotator Cuff Injuries. Ajr. American Journal of Roentgenology. PMID 34161130 DOI: 10.2214/AJR.21.25606  0.033
1996 Price WF, Hynes JP. In-situ strength testing of high strength concrete Magazine of Concrete Research. 48: 189-197. DOI: 10.1680/MACR.1996.48.176.189  0.031
2018 Walsh JP, Farrell TP, Hynes J, Hughes N, O'Byrne C, Eustace SJ. Therapeutic Intervention in Musculoskeletal Radiology: Current Practice and Future Directions. Seminars in Musculoskeletal Radiology. 22: 546-563. PMID 30399619 DOI: 10.1055/s-0038-1672193  0.026
2020 Hynes JP, Fhlatharta MN, Ryan JW, MacMahon PJ, Eustace SJ, Kavanagh EC. Complications in image-guided musculoskeletal injections. Skeletal Radiology. PMID 32734375 DOI: 10.1007/s00256-020-03565-y  0.023
2022 Hynes JP, Glynn D, Eustace SJ. Denervation pseudo hypertrophy of the calf: An important cause of lower limb swelling. Radiology Case Reports. 17: 1702-1704. PMID 35345565 DOI: 10.1016/j.radcr.2022.02.066  0.022
2022 Hynes J, Chabra A, Guirguis M, Kavanagh E. Acetabular paralabral cysts demonstrating perineural propagation. The British Journal of Radiology. 20211306. PMID 35762342 DOI: 10.1259/bjr.20211306  0.02
2020 Hynes JP, Downey RE, Hughes N, O'Keane CJ, Kavanagh E. Subperiosteal hematoma of the iliac wing presenting with leg weakness in a young adult footballer. Radiology Case Reports. 15: 424-426. PMID 32082463 DOI: 10.1016/j.radcr.2020.01.019  0.019
2021 Townsend L, Dowds J, O'Brien K, Sheill G, Dyer AH, O'Kelly B, Hynes JP, Mooney A, Dunne J, Ni Cheallaigh C, O'Farrelly C, Bourke NM, Conlon N, Martin-Loeches I, Bergin C, et al. Persistent Poor Health Post-COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity. Annals of the American Thoracic Society. PMID 33413026 DOI: 10.1513/AnnalsATS.202009-1175OC  0.018
2019 Hynes JP, Hunter K, Rochford M. Utilization and appropriateness in cervical spine trauma imaging: implementation of clinical decision support criteria. Irish Journal of Medical Science. PMID 31292918 DOI: 10.1007/s11845-019-02059-8  0.017
2023 Glynn D, Hynes JP, Marnane M, Kavanagh EC. Electric scooter-related triple cervical artery dissection. Radiology Case Reports. 18: 1342-1344. PMID 36819003 DOI: 10.1016/j.radcr.2022.12.050  0.017
2022 Hynes JP, O'Flaherty M, Glynn D, Eustace S, Kavanagh EC. Imaging of groin pain in athletes: patterns of injury at MRI and gender differences therein. Irish Journal of Medical Science. PMID 35971036 DOI: 10.1007/s11845-022-03126-3  0.015
2020 Hynes J, Murphy M, Gillespie C, Kavanagh E. Our Experience with an Exciting Addition to Contemporary Radiology Literature. Radiology. 192608. PMID 32068509 DOI: 10.1148/radiol.2020192608  0.013
1986 Cayle T, Guth JH, Hynes JT, Kolen EP, Stern ML. Penicillin Distribution During Cheese Manufacture and Membrane Treatment of Whey. Journal of Food Protection. 49: 796-798. PMID 30959601 DOI: 10.4315/0362-028X-49.10.796  0.013
2024 Ryan DT, Hanley M, White A, Hynes JP, Long NM, Eustace SJ, Kavanagh EC. Comparison of 3T MR arthrography and 3T MRI in intra-articular hip pathology: a cost-analysis. Irish Journal of Medical Science. PMID 38743200 DOI: 10.1007/s11845-024-03708-3  0.01
2024 Eustace SK, Hynes J, Byrne AO, Hurley D, Murray O, Eustace S. Percutaneous image-guided treatment of mucoid degeneration of the ACL in advanced knee osteoarthritis-Preliminary observations. Irish Journal of Medical Science. PMID 38349511 DOI: 10.1007/s11845-024-03606-8  0.01
2024 Hanley M, Eustace SK, Ryan DT, McLoughlin S, Hynes JP, Kavanagh EC, Eustace SJ. Are brake response times altered post CT-guided cervical spine nerve root injections? The British Journal of Radiology. PMID 38337059 DOI: 10.1093/bjr/tqae034  0.01
2024 Gillespie CD, Yates A, Hughes M, Ewins K, McMahon G, Hynes J, Murphy MC, Galligan M, Vencken S, Alih E, Varden J, Donnelly J, Bolster F, Rowan M, Foley S, et al. Validating the safety of low-dose CTPA in pregnancy: results from the OPTICA (Optimised CT Pulmonary Angiography in Pregnancy) Study. European Radiology. PMID 38296849 DOI: 10.1007/s00330-024-10593-y  0.01
2023 Hanley M, Ryan DT, Hynes JP, Long NM, Eustace SJ, Kavanagh EC. Imaging of acute lower limb muscle injury and potential gender differences. Irish Journal of Medical Science. PMID 37947993 DOI: 10.1007/s11845-023-03562-9  0.01
2020 Hynes JP, Murphy MC, Gillespie C, Kavanagh EC. Periprosthetic Hip Joint Infection and Its Diagnosis. Radiology. 202755. PMID 32808891 DOI: 10.1148/radiol.2020202755  0.01
2020 Hynes JP, Moore P, Murray JG. Coronavirus Disease (COVID-19) Detected at the Lung Apices During CT Angiography in Acute Stroke Assessment. Ajr. American Journal of Roentgenology. W1. PMID 32538694 DOI: 10.2214/AJR.20.23484  0.01
Hide low-probability matches.